Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis
Status:
RECRUITING
Trial end date:
2027-08-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and clinical efficacy of ISM5411 in adult patients with active ulcerative colitis.